tiprankstipranks
Trending News
More News >
Novo Nordisk (NVO)
NYSE:NVO
US Market
Advertisement

Novo Nordisk (NVO) Technical Analysis

Compare
11,998 Followers

Technical Sentiment

Overall Consensus
Neutral
11Bullish
2Neutral
9Bearish
Technical Analysis Consensus
Sell
3Bullish
2Neutral
5Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Novo Nordisk’s (NVO) Moving Averages Convergence Divergence (MACD) indicator is 0.84, suggesting Novo Nordisk is a Sell.
Novo Nordisk’s (NVO) 20-Day exponential moving average is 56.69, while Novo Nordisk’s (NVO) share price is $61.4, making it a Buy.
Novo Nordisk’s (NVO) 50-Day exponential moving average is 58.06, while Novo Nordisk’s (NVO) share price is $61.4, making it a Buy.

Novo Nordisk (NVO) Pivot Points

Sep 21, 2025, 10:30 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
59.63
60.24
61.04
61.65
62.45
63.06
63.86
Fibonacci
60.24
60.78
61.11
61.65
62.19
62.52
63.06
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Novo Nordisk (NVO) Moving Averages

Sep 21, 2025, 10:30 AM
Period
Simple
Exponential
MA5
58.85Buy
59.35Buy
MA10
56.64Buy
57.81Buy
MA20
56.43Buy
56.69Buy
MA50
56.89Buy
58.06Buy
MA100
63.22Sell
62.93Sell
MA200
72.29Sell
74.25Sell
Novo Nordisk’s (NVO) 10-Day exponential moving average is 57.81, while Novo Nordisk’s (NVO) share price is $61.4, making it a Buy.
Novo Nordisk’s (NVO) 100-Day exponential moving average is 62.93, while Novo Nordisk’s (NVO) share price is $61.4, making it a Sell.
Novo Nordisk’s (NVO) stock price is $61.4 and Novo Nordisk’s (NVO) 50-day simple moving average is 56.89, creating a Buy signal.
Novo Nordisk’s (NVO) stock price is $61.4 and Novo Nordisk’s (NVO) 100-day simple moving average is 63.22, creating a Sell signal.
Novo Nordisk’s (NVO) stock price is $61.4 and Novo Nordisk’s (NVO) 200-day simple moving average is 72.29, creating a Sell signal.

Novo Nordisk (NVO) Technical Indicators

Sep 21, 2025, 10:30 AM
Name
Value
Implied Action
RSI (14)
67.24
Neutral
STOCH (9,6)
90.48
Sell
STOCHRSI (14)
90.48
Sell
MACD (12,26)
0.84
Sell
ADX (14)
16.49
Buy
Williams %R
-9.58
Sell
CCI (14)
232.11
Sell
ATR (14)
1.84
-
Ultimate Oscillator
62.00
Neutral
ROC
8.75
Buy
Novo Nordisk’s (NVO) Relative Strength Index (RSI) is 67.24, creating a Neutral signal.
Novo Nordisk’s (NVO) Trend Strength Indicator (ADX) is 16.49, creating a Buy signal.
Novo Nordisk’s (NVO) Commodity Channel Index (CCI) is 232.11, creating a Sell signal.
Novo Nordisk’s (NVO) Price Rate of Change (ROC) is 8.75, creating a Buy signal.

FAQ

Is NVO a Buy, Hold, or Sell?
Based on NVO’s technical indicators, NVO is a Hold.
    What is NVO’s RSI (14)?
    NVO’s RSI (14) is 67.24, which suggests NVO is a Neutral.
      What is NVO’s MACD?
      NVO’s MACD is 0.84, which suggests NVO is a Sell.
        What is NVO’s 5-day moving average?
        NVO’s 5-day moving average is 58.85, which suggests NVO is a Buy.
          What is NVO’s 20-day moving average?
          NVO 20-day moving average is 56.43, which suggests NVO is a Buy.
            What is NVO’s 50-day moving average?
            NVO’s 50-day moving average is 56.89, which suggests NVO is a Buy.
              What is NVO’s 200-day moving average?
              NVO’s 200-day moving average is 72.29, which suggests NVO is a Sell.
                What is NVO’s Williams % R (14)?
                NVO’s Williams % R (14) is -9.58, which suggests NVO is a Sell.
                  What is NVO’s CCI (14)?
                  NVO’s CCI (14) is 232.11, which suggests NVO is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis